Yu-Xin Xu
Overview
Explore the profile of Yu-Xin Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
707
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stocksdale J, Leventhal M, Lam S, Xu Y, Wang Y, Wang K, et al.
bioRxiv
. 2025 Mar;
PMID: 40060574
Huntington's Disease (HD) is caused by a CAG repeat expansion in the gene encoding Huntingtin (HTT . While normal HTT function appears impacted by the mutation, the specific pathways unique...
2.
Nagai T, Mizoguchi T, Wang Y, Deik A, Bullock K, Clish C, et al.
Sci Rep
. 2025 Feb;
15(1):5036.
PMID: 39934259
Angiopoietin-like 3 (ANGPTL3) is a key regulator of lipoprotein metabolism, known for its potent inhibition on intravascular lipoprotein and endothelial lipase activities. Recent studies have shed light on the cellular...
3.
Dong X, Chen L, Xu Y, Wu P, Xie T, Liu Z
Cancer Gene Ther
. 2025 Jan;
32(2):165-183.
PMID: 39794467
Esophageal cancer (EC) is one of the most common malignancies worldwide with the character of poor prognosis and high mortality. Despite significant advancements have been achieved in elucidating the molecular...
4.
Wu P, Cheng L, Liu Y, Zhang J, Dong X, Chen L, et al.
J Ethnopharmacol
. 2024 Dec;
340():119166.
PMID: 39617083
Ethnopharmacological Relevance: Chinese materia medica (CMM) has a long history and extensive experience in treating ischemic stroke. Wen Ezhu, the rhizome of Curcuma wenyujin Y.H. Chen et C. Ling, is...
5.
Chen L, Xu Y, Wang Y, Ren Y, Dong X, Wu P, et al.
Mol Cancer
. 2024 Oct;
23(1):229.
PMID: 39395984
Background: Prostate cancer (PCa) is one of the most prevalent malignancies in males worldwide. Increasing research attention has focused on the PCa microenvironment, which plays a crucial role in tumor...
6.
Chen L, Chen W, Xu Y, Ren Y, Zheng C, Lin Y, et al.
Eur J Pharmacol
. 2024 Aug;
980:176871.
PMID: 39117263
Non-small cell lung cancer (NSCLC) poses a global health threat, and epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) such as gefitinib, afatinib, and osimertinib have achieved significant success in clinical...
7.
Nagai T, Mizoguchi T, Wang Y, Deik A, Bullock K, Clish C, et al.
bioRxiv
. 2024 Jun;
PMID: 38895318
Angiopoietin-like 3 (ANGPTL3) is a key regulator of lipoprotein metabolism, known for its potent inhibition on intravascular lipoprotein and endothelial lipase activities. Recent studies have shed light on the cellular...
8.
Chen L, Xu Y, Wang Y, Ren Y, Chen Y, Zheng C, et al.
J Ethnopharmacol
. 2024 Apr;
331:118265.
PMID: 38677579
Ethnopharmacological Relevance: Traditional Chinese Medicines (TCMs) have emerged as a promising complementary therapy in the management of prostate cancer (PCa), particularly in addressing resistance to Docetaxel (DTX) chemotherapy. Aim Of...
9.
Li X, Fu Y, Tong X, Zhang Y, Shan Y, Xu Y, et al.
Arch Endocrinol Metab
. 2024 Apr;
68:e230292.
PMID: 38652701
Diabetic retinopathy (DR) is a complication of diabetes with a complex pathophysiology and multiple factors involved. Recently, it has been found that the upregulation of the renin-angiotensin-aldosterone system (RAAS) leads...
10.
Chen L, Xu Y, Wang Y, Zhou J
Asian J Androl
. 2023 Dec;
26(2):123-134.
PMID: 38157428
Prostate cancer (PCa) is one of the most common malignancies in males worldwide, and its development and progression involve the regulation of multiple metabolic pathways. Alterations in lipid metabolism affect...